John R. Daniels

2.9k total citations
34 papers, 2.2k citations indexed

About

John R. Daniels is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, John R. Daniels has authored 34 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Oncology and 7 papers in Hepatology. Recurrent topics in John R. Daniels's work include Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease and Transplantation (3 papers). John R. Daniels is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease and Transplantation (3 papers). John R. Daniels collaborates with scholars based in United States, Australia and France. John R. Daniels's co-authors include Harold M. Fullmer, Gerald S. Lazarus, Robert S. Brown, Margaret E. Billingham, Michael R. Bristow, Jay W. Mason, Donald G. Skinner, Gary Lieskovsky, Howard A. Bladen and William H. Kern and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

John R. Daniels

33 papers receiving 2.0k citations

Peers

Countries citing papers authored by John R. Daniels

Since Specialization

Citations

This map shows the geographic impact of John R. Daniels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Daniels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Daniels more than expected).

Fields of papers citing papers by John R. Daniels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Daniels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Daniels. The network helps show where John R. Daniels may publish in the future.

Co-authorship network of co-authors of John R. Daniels

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Daniels. A scholar is included among the top collaborators of John R. Daniels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Daniels. John R. Daniels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Small-angle neutron scattering studies of porous media: Assessment of liquid and gas as contrast-matching fluids using carbon aerogel 2025 ·Microporous and Mesoporous Materials ·(unknown), A.P. Radliński, Tomasz Blach, Liliana de Campo, Ralf Schweins, John R. Daniels, Klaus Regenauer‐Lieb	0
2	PRINSAS 2.0: a Python-based graphical user interface tool for fitting polydisperse spherical pore models in small-angle scattering analysis of porous materials 2025 ·Journal of Applied Crystallography ·(unknown), Andrzej P. Radliński, Tomasz Blach, John R. Daniels, Klaus Regenauer‐Lieb	1
3	Revealing nanoscale sorption mechanisms of gases in a highly porous silica aerogel 2024 ·Journal of Applied Crystallography ·(unknown), Andrzej P. Radliński, Tomasz Blach, Ralf Schweins, Hartmut Lemmel, John R. Daniels, Klaus Regenauer‐Lieb	3
4	Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI‐110) in Hepatocellular Carcinoma 2018 ·Hepatology ·Minmin Liu, Lian Zhang, Hongtao Li, Toshinori Hinoue, Wanding Zhou, Hitoshi Ohtani, Anthony B. El-Khoueiry, John R. Daniels, Casey L. O’Connell, Tanya B. Dorff, Qianjin Lu, Daniel J. Weisenberger, Gangning Liang	49
5	Variability and accuracy of different software packages for dynamic susceptibility contrast magnetic resonance imaging for distinguishing glioblastoma progression from pseudoprogression 2015 ·Journal of Medical Imaging ·(unknown), Panagiotis Korfiatis, Ravi K. Lingineni, John R. Daniels, Jan C. Buckner, Daniel H. Lachance, Ian F. Parney, Rickey E. Carter, Bradley J. Erickson	21
6	Subselective Intra-arterial Chemotherapy Infusion in the Treatment of Hepatocellular Carcinoma 2010 ·Seminars in Oncology ·John R. Daniels, (unknown)	3
7	Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers 2007 ·Clinical Cancer Research ·Jeffrey N. Weitzel, Saundra S. Buys, William H. Sherman, (unknown), Giske Ursin, John R. Daniels, Deborah J. MacDonald, Kathleen R. Blazer, Malcolm C. Pike, Darcy Spicer	26
8	Treatment with the GnRH agonist (GnRHa) deslorelin (D) and low-dose add-back estradiol (E2) is effective in reducing pain, bleeding and uterine volume (UV) while maintaining bone mineral density (BMD) in women with symptomatic uterine fibroids (UF) 2002 ·Fertility and Sterility ·(unknown), Malcolm C. Pike, John R. Daniels, Darcy Spicer	2
9	Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma 1999 ·Cancer ·Cynthia G. Leichman, (unknown), Manuel Modiano, John R. Daniels, Mark M. Zalupski, James H. Doroshow, William S. Fletcher, John S. Macdonald	26
10	The detection of changes in mammographic densities. 1998 ·PubMed ·Giske Ursin, Melvin A. Astrahan, Martine Salane, Yuri R. Parisky, John G. Pearce, John R. Daniels, Malcolm C. Pike, Darcy Spicer	128
11	Prevalence of Infection Following Hepatic Chemoembolization with Cross-linked Collagen with Administration of Prophylactic Antibiotics 1994 ·Journal of Vascular and Interventional Radiology ·Richard A. Reed, George P. Teitelbaum, John R. Daniels, Michael J. Pentecost, Michael D. Katz	33
12	Hepatic Chemoembolization: Safety with Portal Vein Thrombosis 1993 ·Journal of Vascular and Interventional Radiology ·Michael J. Pentecost, John R. Daniels, George P. Teitelbaum, Phillip Stanley	61
13	Intraarterial Administration of Lidocaine for Analgesia in Hepatic Chemoembolization 1990 ·Journal of Vascular and Interventional Radiology ·(unknown), George P. Teitelbaum, Michael J. Pentecost, Ethel J. Finck, (unknown), (unknown), John R. Daniels	21
14	Unusual antiproliferative effects of transforming growth factors-β 1 andβ 2 against primary cells from human tumors 1989 ·Biotherapy ·(unknown), John M. McPherson, John R. Daniels, Karl A. Piez	6
15	Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics. 1988 ·PubMed ·Darcy Spicer, Bach Ardalan, John R. Daniels, Howard Silberman, Kay Johnson	36
16	Dose-effect and structure-function relationships in doxorubicin cardiomyopathy 1981 ·American Heart Journal ·Michael R. Bristow, Jay W. Mason, Margaret E. Billingham, John R. Daniels	178
17	Chemotherapy of malignant histiocytosis in adults 1977 ·Cancer ·Michael Alexander, John R. Daniels	51
18	Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation. 1977 ·PubMed ·Margaret E. Billingham, Michael R. Bristow, Eli Glatstein, Jay W. Mason, Anna Masek, John R. Daniels	112
19	Collagenolytic Activity of Synovium in Rheumatoid Arthritis 1968 ·New England Journal of Medicine ·Gerald S. Lazarus, John L. Decker, (unknown), John R. Daniels, (unknown), Harold M. Fullmer	57
20	Effect of injected estradiol on the uptake of α-andnoisobutyric acid by tissues of the ovariectomized rat 1961 ·Biochemical Pharmacology ·S M Kalman, John R. Daniels	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact